Search

everythinglearnresearchcommunity

for

Search:↓

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Combined minoxidil and PRP therapy improves hair growth without affecting physical performance.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Minoxidil and finasteride can slow or halt hair loss, but may have side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

People with severe hair loss have lower zinc levels in their blood.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Zinc is important for skin health, and supplements can help treat various skin and hair disorders, but more research is needed for conditions like psoriasis and vitiligo.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.